<HTML>
<HEAD>
   <TITLE>inn8k20081229.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing</TITLE>
</HEAD>

<BODY bgcolor="#ffffff">


<A name="page_1"></A>
<P align=center><FONT face=serif size=4>UNITED STATES</FONT><BR>
<FONT face=serif size=4>SECURITIES AND EXCHANGE COMMISSION</FONT><BR>
<FONT face=serif size=4>WASHINGTON, DC 20549</FONT></P>
<P align=center><B><FONT face=serif size=5>FORM 8-K</FONT></B><BR>
<B><FONT face=serif size=2>CURRENT REPORT</FONT></B></P>
<P align=center><B><FONT face=serif size=2>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</FONT></B></P>
<P align=center><FONT face=serif size=2>Date of report (Date of earliest event reported: December 24, 2008)</FONT></P>
<P align=center><B><FONT face=serif size=5>Innophos Holdings, Inc.</FONT></B><BR>
<FONT face=serif size=1>(Exact name of Registrant as specified in its their Charter)</FONT></P>
<TABLE cellSpacing=0 cellPadding=0 align=center border=0>
<TR>
     <TD width="37%"></TD>
     <TD width="30%"></TD>
     <TD width="31%"></TD></TR>
<TR vAlign=bottom>
     <TD align=center><B><FONT face=serif size=2>Delaware</FONT></B>&nbsp; </TD>
     <TD align=center><B><FONT face=serif size=2>001-33124</FONT></B>&nbsp; </TD>
     <TD align=center><B><FONT face=serif size=2>20-1380758</FONT></B>&nbsp; </TD></TR>
<TR vAlign=bottom>
     <TD align=center><FONT face=serif size=1>(States or other jurisdictions of incorporation)</FONT>&nbsp; </TD>
     <TD align=center><FONT face=serif size=1>(Commission File Numbers)</FONT>&nbsp; </TD>
     <TD align=center><FONT face=serif size=1>(IRS Employer Identification Nos.)</FONT>&nbsp; </TD></TR></TABLE><BR>
<P align=center><B><FONT face=serif size=2>259 Prospect Plains Road</FONT></B><BR>
<B><FONT face=serif size=2>Cranbury, New Jersey 08512</FONT></B></P>
<P align=center><FONT face=serif size=1>(Address of Principal Executive Office, including Zip Code)</FONT></P>
<P align=center><B><FONT face=serif size=2>(609) 495-2495</FONT></B></P>
<P align=center><FONT face=serif size=1>(Registrant&#146;s Telephone Number, Including Area Code)</FONT></P>
<P align=center><B><FONT face=serif size=2>Not Applicable</FONT></B></P>
<P align=center><FONT face=serif size=1>(Former name or former address, if changed since last report)</FONT></P>
<P align=left><FONT face=serif size=2>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: <BR>
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) <BR>
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12) <BR>
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b)) <BR>
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))</FONT></P>
<P align=left>&nbsp;</P>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" noShade SIZE=2>


<A name="page_2"></A>
<P align=left><B><FONT face=serif size=2>Item 8.01 Other Items.</FONT></B></P>
<P align=left>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face=serif size=2>On December 23, 2008, the Registrant received a notification from the Antitrust Division of the U. S. Department of Justice, or DOJ, that a grand jury investigation of the sodium tripolyphosphate (STPP) business had been closed, and that the Registrant was no longer required to maintain documents furnished for that investigation. As previously reported in September 2007, the Registrant had been served with a subpoena to produce documents for an investigation into what the DOJ termed &#147;potential antitrust violations&#148; in the STPP industry focusing on the period from 2002 through 2005. The Registrant cooperated fully in the investigation, and, earlier this year, reported it had delivered substantially all responsive materials to the DOJ.</FONT></P>
<P style="MARGIN-LEFT: 500px" align=left><B><FONT face=serif size=2>SIGNATURES</FONT></B></P>
<P align=left>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face=serif size=2>According to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.</FONT></P>
<P style="MARGIN-LEFT: 500px" align=left><B><FONT face=serif size=2>INNOPHOS HOLDINGS, INC.</FONT></B></P>
<P style="MARGIN-LEFT: 250px" align=left><STRONG><FONT size=2></FONT></STRONG>&nbsp;</P>
<P style="MARGIN-LEFT: 500px" align=left><FONT face=serif size=2>By:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U><FONT face=serif size=2>/s/ Richard Heyse<BR>
</FONT></U><FONT face=serif size=2>Name: Richard Heyse <BR>
Title:&nbsp;&nbsp; Chief Financial Officer</FONT></P>
<P align=left><FONT face=serif size=2>Dated: December 29, 2008</FONT></P>
<P align=center>2</P>
<HR align=center width="100%" color=#bafcf9 noShade SIZE=2>

</BODY>

</HTML>
[{"type": "8-K", "sequence": "1", "filename": "inn8k20081229.htm", "description": "8K", "secsgml_size_bytes": 4996}]
{"company-data": {"conformed-name": "Innophos Holdings, Inc.", "cik": "0001364099", "assigned-sic": "5160", "irs-number": "201380758", "fiscal-year-end": "1207"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-33124", "film-number": "081272790"}, "business-address": {"street1": "259 PROSPECT PLAINS ROAD", "city": "CRANBURY", "state": "NJ", "zip": "08512", "phone": "(609) 495 2495"}, "mail-address": {"street1": "259 PROSPECT PLAINS ROAD", "city": "CRANBURY", "state": "NJ", "zip": "08512"}}
inn8k20081229.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported: December 24, 2008)
Innophos Holdings, Inc.
(Exact name of Registrant as specified in its their Charter)
Delaware
001-33124
20-1380758
(States or other jurisdictions of incorporation)
(Commission File Numbers)
(IRS Employer Identification Nos.)
259 Prospect Plains Road
Cranbury, New Jersey 08512
(Address of Principal Executive Office, including Zip Code)
(609) 495-2495
(Registrant's Telephone Number, Including Area Code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 8.01 Other Items.
On December 23, 2008, the Registrant received a notification from the Antitrust Division of the U. S. Department of Justice, or DOJ, that a grand jury investigation of the sodium tripolyphosphate (STPP) business had been closed, and that the Registrant was no longer required to maintain documents furnished for that investigation. As previously reported in September 2007, the Registrant had been served with a subpoena to produce documents for an investigation into what the DOJ termed "potential antitrust violations" in the STPP industry focusing on the period from 2002 through 2005. The Registrant cooperated fully in the investigation, and, earlier this year, reported it had delivered substantially all responsive materials to the DOJ.
SIGNATURES
According to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
INNOPHOS HOLDINGS, INC.
By:
/s/ Richard Heyse
Name: Richard Heyse
Title:   Chief Financial Officer
Dated: December 29, 2008
2